<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02434575</url>
  </required_header>
  <id_info>
    <org_study_id>14/NE/0128</org_study_id>
    <nct_id>NCT02434575</nct_id>
  </id_info>
  <brief_title>UK ROPE Register Study</brief_title>
  <acronym>UK ROPE</acronym>
  <official_title>ROPE Registry Project to Determine the Safety and Efficacy of Prostate Artery Embolisation (PAE) for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Enlargement (LUTS BPE)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cardiff and Vale University Health Board</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>British Society of Interventional Radiologists</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>British Association of Urological Surgeons</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Instutite of Health and Care Excellence</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Cardiff and Vale University Health Board</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This registry study enables us to collect data on the treatment of LUTS using prostate artery
      embolisation (PAE), and other surgical methods to answer the following questions posed by
      NICE in 2013:

        -  Is PAE a safe and effective treatment option for LUTS caused by prostate enlargement?

        -  How does PAE compare with conventional surgical treatments? This will primarily be a
           surgical procedure called transurethral resection of the prostate (TURP) (see below).

        -  Which patients would most benefit from PAE over the other treatment options?
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a study protocol for the UK ROPE Register for Lower Urinary Tract Symptoms (LUTS).
      This register enables us to collect data on the treatment of LUTS using prostate artery
      embolisation (PAE), and other surgical methods to answer the following questions posed by
      NICE in 2013:

        -  Is PAE a safe and effective treatment option for LUTS caused by prostate enlargement?

        -  How does PAE compare with conventional surgical treatments? This will primarily be a
           surgical procedure called transurethral resection of the prostate (TURP) (see below).

        -  Which patients would most benefit from PAE over the other treatment options? This study
           involves populating the UK ROPE Register with data from patients who have undergone
           prostate artery embolisation (PAE) and the current standard treatment in the UK,
           transurethral resection of the prostate (TURP). All consecutive patients receiving PAE
           in UK sites taking part in this study over the course of 12 months (from the date that
           the first patient is enrolled) will be invited to join the UK ROPE register. At least
           150 PAE patients will be enrolled into this study, and a comparable number of TURP
           patients (at least 150 patients also) from a maximum of 18 sites in the UK. It is
           anticipated that each site will enrol between 10 and 30 PAE patients in 12 months.
           Enrolment will only continue past 12 months until 150 PAE patients have been added to
           the register.

      NICE has suggested keeping a registry or database of patients who have undergone this
      procedure in the UK. so that we can find out more about how safe and effective it is for
      patients and how it compares to the other established treatments available such as surgery.
      The UK ROPE Register will be owned and hosted by the British Society of Interventional
      Radiologists (BSIR) and the British Association of Urological Surgeons (BAUS). The register
      will be built by Dendrite, a commercial company that specialise in making medical registers
      and databases. Cedar, a consortium of Cardiff &amp; Vale UHB and Cardiff University and an
      External Assessment Centre (EAC) to NICE, was commissioned to facilitate the registry
      research. Cedar's role is to work with the steering group (consisting of BSIR, BAUS, and NICE
      representatives) to help build the ROPE Register and ensure that the right data points are
      collected to answer research questions for NICE. Cedar will also perform the data analysis
      from the ROPE Register and will publish the results in a peer-reviewed scientific journal.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>July 2014</start_date>
  <completion_date type="Actual">December 31, 2016</completion_date>
  <primary_completion_date type="Actual">December 2016</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>12 Months</target_duration>
  <primary_outcome>
    <measure>IPSS change for PAE patients, from baseline 12 months post procedure</measure>
    <time_frame>12 months</time_frame>
    <description>Comparison of IPSS questionnaire score at baseline at 12 months post-PAE procedure</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>IPSS comparison of PAE with TURP, 12 months post-procedure</measure>
    <time_frame>12 Months</time_frame>
    <description>Comparison of IPSS score changes between PAE and TURP cases, 12 months post-procedure. Non inferiority study.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Safety of PAE procedure - Number of patients with adverse events up to 12 months post-procedure</measure>
    <time_frame>12 months</time_frame>
    <description>Any anticipated complications of PAE should be recorded on the ROPE Register up to 12 months post-procedure. These include: Local dissection, non-target embolisation, groin haematoma, sepsis, transfusion, TUR syndrome, bladder wall injury, antibiotics needed post-PAE (implying infection), and catheterisation. Patient-reported complications include pain, haematuria, haematospermia, retrograde ejaculation, catheterisation, and hospital re-admission.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>IPSS comparison of other treatments (HoLEP, Open prostatectomy) to PAE, 12 months post-procedure</measure>
    <time_frame>12 months</time_frame>
    <description>Descriptive statistics for comparison of PAE with other treatments (HoLEP, Open prostatectomy) using IPSS.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>IIEF comparison of TURP, HoLEP and Open prostatectomy to PAE, 12 months post-procedure.</measure>
    <time_frame>12 months</time_frame>
    <description>Descriptive statistics for comparison of PAE with other treatments (Open Prostatectomy or laser surgery) using IIEF.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Prostate volume comparison of TURP, HoLEP and Open prostatectomy to PAE, 12 months post-procedure.</measure>
    <time_frame>12 months</time_frame>
    <description>Descriptive statistics for comparison of PAE with other treatments (TURP, Open Prostatectomy or HoLEP) using prostate volume.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Urinary flow study comparison of TURP, HoLEP and Open prostatectomy to PAE, 12 months post-procedure.</measure>
    <time_frame>12 months</time_frame>
    <description>Descriptive statistics for comparison of PAE with other treatments (TURP, Open Prostatectomy or HoLEP) using urinary flow studies.</description>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Actual">318</enrollment>
  <condition>Lower Urinary Tract Symptoms</condition>
  <arm_group>
    <arm_group_label>PAE</arm_group_label>
    <description>Men with LUTS BPE who have opted for PAE at a participating site, and have consented to take part in the UK ROPE Register Study.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>TURP</arm_group_label>
    <description>Men with LUTS BPE who have consented to TURP at a participating site, and have consented to the UK ROPE Register Study.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Other</arm_group_label>
    <description>Men with LUTS BPE who have had an Open Prostatectomy or laser surgery at a participating site, and have consented to the UK ROPE Study.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Men with LUTS BPE who have consented to PAE, TURP, Open prostatectomy or laser surgery at a
        participating UK site.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Men with LUTS who have consented for PAE, TURP, open prostatectomy or laser surgery at
             a participating site

          -  Able to read, write and understand English

          -  Capable of giving informed written consent

        Exclusion Criteria:

          -  Not able to read, write or understand English

          -  Not able/willing to provide informed written consent
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Colchester Hospital University NHS Foundation Trust</name>
      <address>
        <city>Colchester</city>
        <state>Essex</state>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>East Kent Hospitals University NHS Foundation Trust</name>
      <address>
        <city>Canterbury</city>
        <state>Kent</state>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospitals Birmingham NHS Foundation Trust</name>
      <address>
        <city>Birmingham</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Royal Bournemouth and Christchurch NHS Foundation Trust</name>
      <address>
        <city>Bournemouth</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospitals Coventry &amp; Warwickshire NHS</name>
      <address>
        <city>Coventry</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Frimley Park Hospital NHS Found Trust</name>
      <address>
        <city>Frimley</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>NHS Greater Glasgow and Clyde</name>
      <address>
        <city>Glasgow</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hull and East Yorkshire Hospitals NHS Trust</name>
      <address>
        <city>Hull</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Guy's and St Thomas' NHS Foundation Trust</name>
      <address>
        <city>London</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Imperial College Healthcare NHS Trust</name>
      <address>
        <city>London</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Central Manchester University Hospitals NHS Foundation Trust</name>
      <address>
        <city>Manchester</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Newcastle upon Tyne Hospitals NHS Foundation Trust</name>
      <address>
        <city>Newcastle-Upon-Tyne</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Oxford University Hospitals NHS Trust</name>
      <address>
        <city>Oxford</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Plymouth Hospitals NHS Trust</name>
      <address>
        <city>Plymouth</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital Southampton NHS Foundation Trust</name>
      <address>
        <city>Southampton</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital North Staffordshire NHS Trust</name>
      <address>
        <city>Stoke On Trent</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Royal Cornwall Hospitals NHS Trust</name>
      <address>
        <city>Truro</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <link>
    <url>https://onlinelibrary.wiley.com/doi/full/10.1111/bju.14249</url>
    <description>Results from the UK‚ÄêROPE study</description>
  </link>
  <results_reference>
    <citation>Ray AF, Powell J, Speakman MJ, Longford NT, DasGupta R, Bryant T, Modi S, Dyer J, Harris M, Carolan-Rees G, Hacking N. Efficacy and safety of prostate artery embolization for benign prostatic hyperplasia: an observational study and propensity-matched comparison with transurethral resection of the prostate (the UK-ROPE study). BJU Int. 2018 Aug;122(2):270-282. doi: 10.1111/bju.14249. Epub 2018 May 6.</citation>
    <PMID>29645352</PMID>
  </results_reference>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>March 20, 2015</study_first_submitted>
  <study_first_submitted_qc>May 4, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 5, 2015</study_first_posted>
  <last_update_submitted>February 6, 2020</last_update_submitted>
  <last_update_submitted_qc>February 6, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 7, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Cardiff and Vale University Health Board</investigator_affiliation>
    <investigator_full_name>Dr Grace Carolan-Rees</investigator_full_name>
    <investigator_title>Cedar Director</investigator_title>
  </responsible_party>
  <keyword>Lower Urinary Tract Symptoms</keyword>
  <keyword>Prostatic artery embolisation</keyword>
  <keyword>Transurethral resection of the prostate</keyword>
  <keyword>Benign prostatic hyperplasia</keyword>
  <keyword>Benign prostatic enlargement</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lower Urinary Tract Symptoms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

